The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis
Abstract
Alzheimer’s disease is the leading cause of dementia. Its increased prevalence in developed countries, due to the sharp rise in ageing populations, presents one of the costliest challenges to modern medicine. In order to find disease-modifying therapies to confront this challenge, a more complete understanding of the pathogenesis of Alzheimer’s disease is necessary. Recent studies have revealed increasing evidence for the roles played by microglia, the resident innate immune system cells of the brain. Reflecting the well-established roles of microglia in reacting to pathogens and inflammatory stimuli, there is now a growing literature describing both protective and detrimental effects for individual cytokines and chemokines produced by microglia in Alzheimer’s disease. A smaller but increasing number of studies have also addressed the divergent roles played by microglial neurotrophic and neurogenic factors, and how their perturbation may play a key role in the pathogenesis of Alzheimer’s disease. Here we review recent findings on the roles played by microglia in neuroinflammation, neuronal survival and neurogenesis in Alzheimer’s disease. In each case, landmark studies have provided evidence for the divergent ways in which microglia can either promote neuronal function and survival, or perturb neuronal function, leading to cell death. In many cases, the secreted molecules of microglia can lead to divergent effects depending on the magnitude and context of microglial activation. This suggests that microglial functions must be maintained in a fine equilibrium, in order to support healthy neuronal function, and that the cellular microenvironment in the Alzheimer’s disease brain disrupts this fine balance, leading to neurodegeneration. Thus, an understanding of microglial homeostasis, both in health and across the trajectory of the disease state, will improve our understanding of the pathogenic mechanisms underlying Alzheimer’s disease, and will hopefully lead to the development of microglial-based therapeutic strategies to restore equilibrium in the Alzheimer’s disease brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, in recent years, microglia have been increasingly recognized as key modulators of AD pathogenesis (D'Errico et al., 2022;Pascoal et al., 2021;Gray et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Gray et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 1×
“Whilst the biomechanisms behind many of these genetic risk factors are yet to be characterized, a few key protein-coding genes (including APOE, TREM2, CD33, PGRN, CR1 and NLRP3) have been associated with disease-conferring pathways (Lambert et al., 2013; Dos Santos et al., 2017).”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 4×
“In addition, DAP12 promotes the activation of chemotaxis, phagocytosis and the upregulation of key inflammasome components including NLR family pyrin domain containing 3 (NLRP3) (Heneka et al., 2013; Wang et al., 2015).”
BackgroundInfluentialVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · cited 1×
“The predominant negative lesions, neuronal death and synaptic loss, are strong correlates of cognitive impairment, and synaptic connections are thought to act as biological gateways to allow the propagation of neuropathology through the connectome of the brain (Seeley et al., 2009).”
BackgroundHammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225 · cited 2×
“Recent studies of in vivo microglia using single-cell RNA sequencing reveal that whilst the heterogeneity of myeloid cells in the brains of healthy mice decrease from embryonic stages of development to adulthood, in ageing and in demyelinating injury conditions, multiple distinct subpopulations of inflammatory microgl…”
BackgroundTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · cited 1×
“In AD patients, neurons of the hippocampus, and to a lesser extent those of the cerebellar cortex, show a significant reduction in the responsiveness of their IGF-1R/IRS-2/PI3K signaling pathway, which is associated with cognitive decline and disease progression (Talbot et al., 2012).”
BackgroundNeuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · cited 1×
“The M2c secretory profile is dominated by the expression of transforming growth factor beta (TGF-β) and sphingosine lipid kinase, which promotes tissue repair and matrix remodelling (Cherry et al., 2014).”
BackgroundMicroglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“In organotypic hippocampal slices, Aβ oligomers act through an NMDAR-dependant mechanism to decrease dendritic spine density and trigger progressive loss of active glutamatergic synapses in pyramidal neurons (Shankar et al., 2007).”
BackgroundMoreno-Jiménez, E. P., Flor-García, M., Terreros-Roncal, J., Rábano, A., Cafini, F., Pallas-Bazarra, N., Ávila, J., & Llorens-Martín, M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0375-9 · Cited by 1,577 · cited 1×
“…and colleagues, using stringent sample exclusion criteria, and an innovative tissue processing approach, found thousands of DCX positive neurons in the DG of 13 neurologically healthy adult brain tissue samples, which were absent from proximal non-neurogenic regions (Moreno-Jiménez et al., 2019).”
BackgroundInflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
Human Hippocampal Neurogenesis Persists throughout Aging
Boldrini, M., Fulmore, C. A., Tartt, A. N., Simeon, L. R., Pavlova, I., Poposka, V., Rosoklija, G. B., Stankov, A., Arango, V., Dwork, A. J., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.015 · Cited by 1,345 · cited 1×
“In another recent study, Boldrini et al. (2018) quantified neuronal progenitor cells in autopsied hippocampi from healthy human individuals between 14 and 79 years of age.”
BackgroundMicroglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 2×
“However, these microglial activities are subject to an age-related, Aβ-contingent decline, coincident with a two- to five-fold downregulation in Aβ-degrading enzymes, namely neprilysin, insulin-degrading enzyme and matrix metalloprotease-9, as well as in scavenger receptors known to recognize Aβ, including receptors f…”
BackgroundLi, Q., Cheng, Z., Zhou, L., Darmanis, S., Neff, N. F., Okamoto, J., Gulati, G., Bennett, M. L., Sun, L. O., Clarke, L. E., et al. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.006 · Cited by 1,129
Adult Neurogenesis in the Hippocampus: From Stem Cells to Behavior
Gonçalves, J. T., Schafer, S. T., & Gage, F. H. (2016) · Cell · doi:10.1016/j.cell.2016.10.021 · Cited by 1,122
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
ApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876
The many faces of insulin-like peptide signalling in the brain
Fernandez, A. M., & Torres-Alemán, I. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3209 · Cited by 872 · cited 1×
“Microglial insulin-like growth factor and neuronal survival The effect of IGF signaling on neural cell growth and survival is highly complex and under physiological conditions can be seen as an evolutionarily conserved system for resource allocation (Fernandez and Torres-alemán, 2012).”
BackgroundApolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Holtzman, D. M., Herz, J., & Bu, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006312 · Cited by 782 · cited 1×
“ApoE is synthesized by astrocytes and microglia, and lipidated by ATP-binding cassette A1 to form lipoprotein particles (Holtzman et al., 2012).”
BackgroundTREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727 · cited 1×
“…(PRRs), including toll-like receptors, receptors for advanced glycation end products, and scavenger receptors, many of which can recognize different Aβ species through various interactions of differing affinity (EI Khoury et al., 1996; Landreth and Reed-Geaghan, 2009; Venegas and Heneka, 2017).”
BackgroundBohlen, C. J., Bennett, F. C., Tucker, A. F., Collins, H. Y., Mulinyawe, S. B., & Barres, B. A. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.043 · Cited by 658
Holtman, I. R., Raj, D. D., Miller, J. A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P. D., Möller, T., Orre, M., Kamphuis, W., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0203-5 · Cited by 619 · cited 2×
“In vivo, the phenotype of any individual activated microglial cell resides along the continuum between M1 and M2, which is reflected in the unique expression signature of cell-surface markers (Holtman et al., 2015).”
BackgroundApolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587 · cited 1×
“Trem2 is able to bind to all ApoE isoforms and enables microglia to engulf Aβ-lipoprotein complexes more efficiently than naked Aβ (Atagi et al., 2015; Bailey et al., 2015).”
BackgroundTesting the Right Target and Right Drug at the Right Stage
Sperling, R. A., Jack, C. R., & Aisen, P. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002609 · Cited by 550
Sakamoto, K., Karelina, K., & Obrietan, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07080.x · Cited by 543 · cited 1×
“NMDARs mediate increased Ca2+ influx into the soma cytosol, activating CaM kinase IV, which phosphorylates CREB, allowing it to promote the transcription of multiple target genes encoding anti-apoptotic and neurotrophic molecules (Sakamoto et al., 2013).”
BackgroundThe Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Necroptosis activation in Alzheimer's disease
Caccamo, A., Branca, C., Piras, I. S., Ferreira, E., Huentelman, M. J., Liang, W. S., Readhead, B., Dudley, J. T., Spangenberg, E. E., Green, K. N., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4608 · Cited by 482
TREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440 · cited 1×
“Multiple independent studies have identified several key TREM2 lossof-function risk variants as being significantly associated with AD, the most common of which is the R47H variant, which increases the risk of AD threefold (Guerreiro et al., 2013; Yeh et al., 2017).”
BackgroundShaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · cited 1×
“For example, in the APP/PS1 mouse model of AD, overexpression of IL-1β in the hippocampus leads to reduced Aβ pathology and plaque formation (Shaftel et al., 2007).”
BackgroundTREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Griciuc, A., Patel, S., Federico, A. N., Choi, S. H., Innes, B. J., Oram, M. K., Cereghetti, G., McGinty, D., Anselmo, A., Sadreyev, R. I., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.010 · Cited by 378 · cited 2×
“Transcriptomic profiling of microglia in these CD33 knockout mice revealed upregulated expression of genes involved in phagocytosis and cellular signaling, again in a TREM2-dependent manner (Griciuc et al., 2019).”
BackgroundCraft, S., Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., Dahl, D., Caulder, E., Neth, B., Montine, T. J., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161256 · Cited by 335
Elucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325
Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain
Chen, Z., Jalabi, W., Hu, W., Park, H.-J., Gale, J. T., Kidd, G. J., Bernatowicz, R., Gossman, Z. C., Chen, J. T., Dutta, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5486 · Cited by 319 · cited 4×
“Microglia extend their processes into the cleft between the pre-synaptic and post-synaptic components of axosomatic synapses to detach their connection and prevent GABAergic signalling (Chen et al., 2014).”
BackgroundInfluentialBattista, D., Ferrari, C. C., Gage, F. H., & Pitossi, F. J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04539.x · Cited by 306 · cited 1×
“In addition, TGF-β has the capacity to promote neurogenesis in vitro, and blockade of TGF-β signaling reduces the percentage of PSA-NCAM positive cells in vivo (Battista et al., 2006).”
BackgroundThe Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303
Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease
Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296
TOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272
Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
Villegas-Llerena, C., Phillips, A., Garcia-Reitboeck, P., Hardy, J., & Pocock, J. M. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.004 · Cited by 270
Griffin, W. S. T., & Mrak, R. E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.233 · Cited by 248 · cited 1×
“In vivo, IL-1β can increase tau hyperphosphorylation and the formation of neurofibrillary tangles, through its activation of MAPK-p38, and can contribute to Aβ plaque formation (Griffin and Mrak, 2002; Sheng et al., 2001).”
BackgroundMicroglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
McQuade, A., & Blurton-Jones, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.045 · Cited by 244
Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models
Minami, S. S., Min, S.-W., Krabbe, G., Wang, C., Zhou, Y., Asgarov, R., Li, Y., Martens, L. H., Elia, L. P., Ward, M. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3672 · Cited by 237
Danger-associated molecular patterns in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0416-204r · Cited by 236
Zhang, J., Malik, A., Choi, H. B., Ko, R. W. Y., Dissing-Olesen, L., & MacVicar, B. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.043 · Cited by 234
Parajuli, B., Sonobe, Y., Horiuchi, H., Takeuchi, H., Mizuno, T., & Suzumura, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.503 · Cited by 232
Pereira Diniz, L., Tortelli, V., Matias, I., Morgado, J., Bérgamo Araujo, A. P., Melo, H. M., Seixas da Silva, G. S., Alves-Leon, S. V., de Souza, J. M., Ferreira, S. T., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3351-16.2017 · Cited by 171 · cited 2×
“In this way, microglial and astrocytic TGF-β signaling axes have been shown to reduce AD-associated dendritic spine loss in hippocampal neurons, and to increase performance in memory tasks in vivo (Diniz et al., 2017).”
BackgroundDistribution of insulin in trigeminal nerve and brain after intranasal administration
Lochhead, J. J., Kellohen, K. L., Ronaldson, P. T., & Davis, T. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-39191-5 · Cited by 146 · cited 1×
“Consistent with this idea, therapeutic upregulation of the downstream PI3K-PKB signaling pathway through CNS intranasal insulin treatment has been found to enhance memory and cognition in both murine models and in limited human trials (Craft et al., 2017; Lochhead et al., 2019).”
BackgroundTansey, K. E., Cameron, D., & Hill, M. J. (2018) · Genome Medicine · doi:10.1186/s13073-018-0523-8 · Cited by 115 · cited 2×
“These open chromatin sites contain consensus DNA-binding motifs for macrophage/ microglial specific transcription factors, including SPI1 and MEF2 (Tansey et al., 2018).”
BackgroundMicroglia regulate hippocampal neurogenesis during chronic neurodegeneration
De Lucia, C., Rinchon, A., Olmos-Alonso, A., Riecken, K., Fehse, B., Boche, D., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.001 · Cited by 110
TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
Zheng, H., Cheng, B., Li, Y., Li, X., Chen, X., & Zhang, Y.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00395 · Cited by 94
Mann, D. M. A., Iwatsubo, T., Pickering-Brown, S. M., Owen, F., Saido, T. C., & Perry, R. H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13294-8 · Cited by 91 · cited 1×
“In accordance with this, in an AD patient cohort, the deposition of Aβ has been found to correlate positively with the number of ε4 alleles at the ApoE locus (Mann et al., 1997).”
Result
Research works printed but not linked: 59
- Appel, 2018, Increased microglial activity, impaired adult hippocampal neurogenesis, and depressive-like behavior in microglial VPS35-depleted mice, J Neurosci, 38, 5949, 10.1523/JNEUROSCI.3621-17.2018 · DOI
- Augustin, 2018, Impact of insulin signaling and proteasomal activity on physiological output of a neuronal circuit in aging Drosophila melanogaster, Neurobiol Aging, 66, 149, 10.1016/j.neurobiolaging.2018.02.027 · DOI
- Augustin, 2017, Reduced insulin signaling maintains electrical transmission in a neural circuit in aging flies, PLoS Biol, 15, e2001655, 10.1371/journal.pbio.2001655 · DOI
- Bachstetter, 2015, Disease-related microglia heterogeneity in the hippocampus of Alzheimer’s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging, Acta Neuropathol Commun, 3, 32, 10.1186/s40478-015-0209-z · DOI · Paper page
- Barclay, 2002, CD200 and membrane protein interactions in the control of myeloid cells, Trends Immunol, 23, 285, 10.1016/S1471-4906(02)02223-8 · DOI · Paper page
- Boekhoorn, 2006, Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus, Neurobiol Dis, 24, 1, 10.1016/j.nbd.2006.04.017 · DOI · Paper page
- Braak, 1995, Staging of Alzheimer’s disease-related neurofibrillary changes, Neurobiol Aging, 16, 271, 10.1016/0197-4580(95)00021-6 · DOI · Paper page
- Cacci, 2008, In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia, Glia, 425, 412, 10.1002/glia.20616 · DOI · Paper page
- Cavanagh, 2018, Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling, IBRO Rep, 4, 18, 10.1016/j.ibror.2018.01.003 · DOI
- Choi, 2008, Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation, Neuron, 59, 568, 10.1016/j.neuron.2008.07.033 · DOI · Paper page
- Clayton, 2017, Alzheimer’s disease: the role of microglia in brain homeostasis and proteopathy, Front Neurosci, 11, 1, 10.3389/fnins.2017.00680 · DOI
- Cohen, 2009, Reduced IGF-1 signaling delays age-associated proteotoxicity in mice, Cell, 139, 1157, 10.1016/j.cell.2009.11.014 · DOI · Paper page
- Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Crocker, 2002, Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell–cell interactions and signalling, Curr Opin Struct Biol, 12, 609, 10.1016/S0959-440X(02)00375-5 · DOI · Paper page
- Dos Santos, 2017, Validating GWAS variants from microglial genes implicated in Alzheimer’s disease, J Mol Neurosci, 62, 215, 10.1007/s12031-017-0928-7 · DOI
- Encinas, 2011, Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus, Cell Stem Cell, 8, 566, 10.1016/j.stem.2011.03.010 · DOI · Paper page
- Eriksson, 1998, Neurogenesis in the adult human hippocampus, Nat Med, 4, 1313, 10.1038/3305 · DOI · Paper page
- Fan, 2017, Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders, Neural Regen Res, 12, 366, 10.4103/1673-5374.202926 · DOI
- Femminella, 2019, Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume, Neurology, 92, 1331, 10.1212/WNL.0000000000007133 · DOI
- Ferreira, 2018, Variants in Alzheimer’s disease, J Mol Neurosci, 64, 471
- Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
- Gomes-Leal, 2019, Why microglia kill neurons after neural disorders? The friendly fire hypothesis, Neural Regen Res, 14, 1499, 10.4103/1673-5374.255359 · DOI
- Hickman, 2013, The microglial sensome revealed by direct RNA sequencing, Nat Neurosci, 16, 1896, 10.1038/nn.3554 · DOI · Paper page
- Hoek, 2000, Down-regulation of the macrophage lineage through interaction with OX2 ( CD200), Science, 290, 1768, 10.1126/science.290.5497.1768 · DOI · Paper page
- Kandimalla, 2017, Is Alzheimer’s disease a type 3 diabetes? A critical appraisal, Biochim Biophys Acta Mol Basis Dis, 1863, 1078, 10.1016/j.bbadis.2016.08.018 · DOI · Paper page
- Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer’s disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
- Kuhn, 2015, Control of cell survival in adult mammalian neurogenesis, Cold Spring Harb Perspect Biol, 10.1101/cshperspect.a018895 · DOI
- Kwilasz, 2015, The therapeutic potential of interleukin-10 in neuroimmune diseases, Neuropharmacology, 96, 55, 10.1016/j.neuropharm.2014.10.020 · DOI · Paper page
- Labandeira-Garcia, 2017, Insulin-like growth factor-1 and neuroinflammation, Front Aging Neurosci, 9, 365, 10.3389/fnagi.2017.00365 · DOI · Paper page
- Landreth, 2009, Toll-like receptors in Alzheimer’s disease, Curr Top Microbiol Immunol, 336, 137
- Li, 2015, CD33 rs3865444 polymorphism contributes to Alzheimer’s disease susceptibility in Chinese, European, and North American populations, Mol Neurobiol, 52, 414, 10.1007/s12035-014-8880-9 · DOI
- Mandrekar, 2010, Microglia and inflammation in Alzheimer’s disease, CNS Neurol Disord Drug Targets, 9, 156, 10.2174/187152710791012071 · DOI · Paper page
- Mir, 2017, IGF-1 mediated neurogenesis involves a novel RIT1/Akt/Sox2 cascade, Sci Rep, 7, 3283, 10.1038/s41598-017-03641-9 · DOI
- Montgomery, 2011, Ablation of TNF-RI/RII expression in Alzheimer’s disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain, Am J Pathol, 179, 2053, 10.1016/j.ajpath.2011.07.001 · DOI · Paper page
- Myhre, 2019, Microglia express insulin-like growth factor-1 in the hippocampus of aged APPswe/PS1dE9 transgenic mice, Front Cell Neurosci, 13, 308, 10.3389/fncel.2019.00308 · DOI
- Nikolakopoulou, 2013, Activated microglia enhance neurogenesis via trypsinogen secretion, Proc Natl Acad Sci U S A, 110, 8714, 10.1073/pnas.1218856110 · DOI
- Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
- Park, 2017, The Alzheimer’s disease-associated R47H variant of TREM2 has an altered glycosylation pattern and protein stability, Front Neurosci, 10, 618, 10.3389/fnins.2016.00618 · DOI
- Pluchino, 2008, Persistent inflammation alters the function of the endogenous brain stem cell compartment, Brain, 131, 2564, 10.1093/brain/awn198 · DOI · Paper page
- Qian, 2008, Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia, J Immunol, 181, 660, 10.4049/jimmunol.181.1.660 · DOI
- Satoh, 2018, Gene expression profiles of M1 and M2 microglia characterized by Public Datasets, Clin Exp Neuroimmunol, 9, 124, 10.1111/cen3.12426 · DOI
- Sheng, 2001, Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer’s disease: potential significance for tau protein phosphorylation, Neurochem Int, 39, 341, 10.1016/S0197-0186(01)00041-9 · DOI · Paper page
- Sorrells, 2018, Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults, Nature, 555, 377, 10.1038/nature25975 · DOI · Paper page
- Steculorum, 2014, The paradox of neuronal insulin action and resistance in the development of aging-associated diseases, Alzheimers Dement, 10, S3, 10.1016/j.jalz.2013.12.008 · DOI
- Tan, 2013, NLRP3 polymorphisms are associated with late-onset Alzheimer’s disease in Han Chinese, J Neuroimmunol, 265, 91, 10.1016/j.jneuroim.2013.10.002 · DOI
- Tang, 2016, Differential roles of M1 and M2 microglia in neurodegenerative diseases, Mol Neurobiol, 53, 1181, 10.1007/s12035-014-9070-5 · DOI · Paper page
- Taylor, 2017, TGF- β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage, J Clin Invest, 127, 280, 10.1172/JCI88647 · DOI · Paper page
- Tepavčević, 2011, Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis, J Clin Invest, 121, 4722, 10.1172/JCI59145 · DOI
- Tong, 2016, Role of microglia in embryonic neurogenesis, Exp Biol Med (Maywood), 241, 1669, 10.1177/1535370216664430 · DOI
- Verkhratsky, 2013, Astroglia in neurological diseases, Futur Neurol, 8, 149, 10.2217/fnl.12.90 · DOI · Paper page
- Wachs, 2006, Transforming growth factor-beta1 is a negative modulator of adult neurogenesis, J Neuropathol Exp Neurol, 65, 358, 10.1097/01.jnen.0000218444.53405.f0 · DOI · Paper page
- Walton, 2006, Microglia instruct subventricular zone neurogenesis, Glia, 54, 815, 10.1002/glia.20419 · DOI · Paper page
- Wang, 2015, TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model, Cell, 160, 1061, 10.1016/j.cell.2015.01.049 · DOI · Paper page
- Wine, 2009, IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells, Neurotox Res, 16, 280, 10.1007/s12640-009-9060-y · DOI
- Yuan, 2016, TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy, Neuron, 90, 724, 10.1016/j.neuron.2016.05.003 · DOI · Paper page
- Zheng, 2017, TREM2 promotes microglial survival by activating Wnt/β-catenin pathway, J Neurosci, 37, 1772, 10.1523/JNEUROSCI.2459-16.2017 · DOI · Paper page
- Zheng, 2010, NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice, J Clin Invest, 120, 2446, 10.1172/JCI33144 · DOI
- Zhong, 2018, Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2), Mol Neurodegener, 13, 15, 10.1186/s13024-018-0247-7 · DOI · Paper page
- Zuroff, 2017, Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes, Cell Mol Life Sci, 74, 2167, 10.1007/s00018-017-2463-7 · DOI · Paper page
Cited by
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343
“chemokines, and reactive oxygen and nitrogen species (Butovsky and Weiner, 2018; Gray et al., 2020).”
Moulton, M. J., Barish, S., Ralhan, I., Chang, J., Goodman, L. D., Harland, J. G., Marcogliese, P. C., Johansson, J. O., Ioannou, M. S., & Bellen, H. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112095118 · Cited by 180
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Metadata
- Authors
- Gray, S. C., Kinghorn, K. J., & Woodling, N. S.
- Affiliations
- Institute of Healthy Ageing and Department of Genetics, Evolution and Environment, University College London, London, UK
- Venue
- Neural Regeneration Research
- Published
- 2020-01-09
- Volume
- 15
- Issue
- 7
- Pages
- 1208-1219
- ISSN
- 1673-5374
- 1876-7958
- Cited by
- 74
- References
- 55
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.